BioNTech SE ADR buy Gilbert
Start price
13.01.21
/
60%
€84.76
Target price
€103.00
Performance (%)
14.43%
End price
08.02.21
€96.99
Summary
This prediction ended on 08.02.21 with a price of €96.99. The BUY prediction by Gilbert finished with a performance of 14.43%. Gilbert has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
According to Gilbert what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
Growths faster than the competition
Could be worthwhile Investment >10% per year
Cons
High risks in the balance sheet
Comments by Gilbert for this prediction
In the thread Biontech SE diskutieren
Buy mit Kursziel 120,0
Kursziel geändert auf 0,0
Kursziel gesetzt auf 95,0
Kursziel geändert auf 100,0
Kursziel geändert auf 103,0
In the thread Trading Biontech SE
Buy beendet
Stopped prediction by Gilbert for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€291.70
23.09.21
23.09.21
-
23.09.25
23.09.25
-67.72%
12.01.24
12.01.24
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€378.60
10.08.21
10.08.21
-
10.08.24
10.08.24
2.06%
10.08.21
10.08.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€184.50
09.07.21
09.07.21
-
09.07.22
09.07.22
-0.11%
09.07.21
09.07.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€162.50
10.05.21
10.05.21
-
10.05.26
10.05.26
1.60%
27.05.21
27.05.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€125.05
17.04.21
17.04.21
-
17.04.23
17.04.23
5.28%
06.05.21
06.05.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€99.38
08.02.21
08.02.21
-
08.02.22
08.02.22
26.58%
16.04.21
16.04.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€96.99
08.02.21
08.02.21
-
08.02.22
08.02.22
2.46%
08.02.21
08.02.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet